About

An independent clinical research lab offering the best approaches for safety, home use, and claim substantiations tests and evaluations, the expertise of experienced clinicians and scientists, and the precision of world-class bioengineering technologies and techniques.   

 

Our History of Research Innovation and Continuing Client Success...

1914
Henry Field Smyth Sr., M.D., professor of Industrial Hygene, established a laboratory for the evaluation of the effects of industrial environments on the health of workers on the University of Pennsylvania campus in Philadelphia.

1935
Dr. Smyth brought Herman A. Shelanski, Ph.D. on as a partner and associate.

1945
After Dr. Smyth's retirement, Dr. Herman Shelanski assumed the directorship and proprietership of the comany, which he renamed as Industrial Toxicology Laboratories, Inc.

1951
Morris V. Shelanski, M.D. becomes medical director of Industrial Toxicology Laboratories, Inc.

1952
Drs. Herman Shelanski and Morris V. Shelanski publish an article describing the human repeat insult patch test, an innovative method of evaluating and distinguishing between irritating and sensitizing propensities of products.

1954
Following the death of Dr. Herman A. Shelanski, Dr. Morris V. Shelanski became director of the laboratories. Under his guidance, the pioneering efforts of Dr. Smyth and Dr. Herman Shelanski were carried forth with the new investigational technology and organizational growth. Throughout the following decades, the company designed, coordinated and conducted clinical investigations to determine the safety and efficacy of drugs, medical devices, household products and industrial chemicals.

1960s
The laboratories became increasingly involved in the clinical evaluation for the safety and efficacy of toiletries and cosmetics.

1975
Because of the increasing emphasis on clinical evaluations, the company's name was changed to Products Investigation, Inc. (PII)

1986
Joseph B. Shelanski, BS becomes president of PII.

1993
PII opens a clinical facility in Modesto, California.

2000
Samuel D. Shelanski, BA becomes president of PII.

2007
Acquired Dr. Albert M. Kligman's S.K.I.N. Incorporated laboratory, clinical trial expertise, and staff clinicians.

2015

Continuing 70+ years of client success and trust.